Study to Evaluate Hormone Patterns and Ovarian Follicular Activity With DR-1021

Study Title
A Study to Evaluate Hormone Patterns and Ovarian Follicular Activity With DR-1021
Teva Identifier
DR-DSG-302
ClinicalTrials.gov Identifier
NCT00544882
Study Status
Completed
Trial Condition(s)
Healthy
Interventions
Drug: DR-1021 | Drug: Mircetteֲ® | Drug: Karivaֲ®

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
Print

Click for participation criteria and map of study locations


Key Participation Requirements

Gender
Female
Age Range
18 Years to 35 Years
Trial Duration
10/01/2007 - 03/01/2008
Phase
Phase 3

Study Type

Interventional